Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

Completed

• Conditions: Chronic Respiratory Disease; Hypoxemia

• Registration Number: NCT03188588
• Lead Sponsor: SOS Oxygene Mediterranee

Brief Summary

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01
• Status Verified: 2017-06
• Study First Submitted: 2017-06-12
• Study First Submitted QC: 2017-06-13
• Study First Posted: 2017-06-15
• Primary Completion: 2019-01
• Study Completion: 2020-01-01
• Last Update Submitted: 2020-09-22
• Last Update Posted: 2020-09-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• chronic respiratory disease patients with chronic hypoxemia
• First prescribed long term oxygenotherapy

Exclusion Criteria

• patients with NIV and CPAP
• vital pronostic < 3 months

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
oxygen use	6 month	time of oxygen use

Secondary Outcome Measures

Name	Time	Method
precarity score assessed by a questionnaire (EPICE)	baseline
quality of life assessed by a questionnaire (VQ-11)	baseline, 3 month and 6 month
respiratory disease severity based on GOLD standards	baseline

Trial Locations

Locations (1)

CHU Arnaud de Villeneuve; 🇫🇷 Montpellier, France